「nov」の検索結果
24件：1～5件目を表示
-
General Announcement: November 1, 2023 Senju Pharmaceutical Co., Ltd. Launch of Distribution of the OptiLight M22 IPL Model Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. S...
https://www.senju.co.jp/system/files/content_news/2023-11/ENG__20231101_0.pdf -
harmaceutical Co., Ltd. Senju has Applied for Manufacturing and Marketing Approval in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf -
General Announcement: November 1, 2023 Senju Pharmaceutical Co., Ltd. Launch of Distribution of the OptiLight M22 IPL Model Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. S...
https://www.senju.co.jp/system/files/content_news/2023-11/ENG__20231101.pdf -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
） SJP-0170GlaucomaP3（Japan） SJP-0154Dry eyeP2（Japan） SJP-0049Allergic ConjunctivitisP2（Japan） As of November 2025
http://www.senju.co.jp/english/rd/pipeline.html -
harmaceutical Co., Ltd. Senju has successfully completed Phase III clinical trials in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716.pdf